This HTML5 document contains 65 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q38148841
rdf:type
wikibase:Item
schema:description
artículo científico scienca artikolo مقالة علمية نشرت في 10 سبتمبر 2013 научни чланак scientific article published on 10 September 2013 artikull shkencor vitenskapelig artikkel vetenskaplig artikel article científic наукова стаття, опублікована у вересні 2013 wissenschaftlicher Artikel vitskapeleg artikkel vědecký článek artículu científicu espublizáu en 2013 বৈজ্ঞানিক নিবন্ধ bilimsel makale articol științific 2013 թվականի սեպտեմբերի 10-ին հրատարակված գիտական հոդված научная статья artigo científico videnskabelig artikel artikel ilmiah artigo científico articolo scientifico scientific article published on 10 September 2013 מאמר מדעי vedecký článok article scientifique wetenschappelijk artikel scientific article published on 10 September 2013 artigo científico
p:P577
wds:Q38148841-53F84AB3-BBDC-4DFA-91DE-757F19B6EE7E
wdt:P577
2013-09-10T00:00:00Z
rdfs:label
Partnership and consent in MS treatment choice Partnership and consent in MS treatment choice Partnership and consent in MS treatment choice
skos:prefLabel
Partnership and consent in MS treatment choice Partnership and consent in MS treatment choice Partnership and consent in MS treatment choice
schema:name
Partnership and consent in MS treatment choice Partnership and consent in MS treatment choice Partnership and consent in MS treatment choice
p:P50
wds:Q38148841-E1A3E56A-428C-4BD4-A55B-26575DB3DCFC
wdt:P50
wd:Q30353183
p:P1476
wds:Q38148841-7211C34A-9637-4E35-95A1-AE87BEDBF9BC
wdt:P1476
Partnership and consent in MS treatment choice
p:P304
wds:Q38148841-9601C60A-5803-4DAC-968C-931CF3825F68
wdt:P304
5-8
p:P31
wds:Q38148841-32C85456-351C-4E6E-8641-D33E041E4717
wdt:P31
wd:Q13442814
p:P921
wds:Q38148841-57D7ECDF-42FA-4CDB-81E6-AAB8E3FF4238
wdt:P921
wd:Q764527
p:P698
wds:Q38148841-43D4BE31-80C5-4EEE-B48E-2572075CBBA7
wdtn:P698
n5:24090756
wdt:P698
24090756
p:P1433
wds:Q38148841-29B09DCB-74E2-4EC3-94D4-9AAB59CD56D7
wdt:P1433
wd:Q6296168
p:P433
wds:Q38148841-7435B4EF-DC47-4983-8074-F6D6C80AD597
p:P478
wds:Q38148841-B9664A80-102B-4818-A3C2-777C300C008F
wdt:P433
1-2
wdt:P478
335
p:P356
wds:Q38148841-4B3672C9-BFEA-4A09-BA90-386EECF8258B
wdtn:P356
n11:J.JNS.2013.09.001
wdt:P356
10.1016/J.JNS.2013.09.001